|
Age (median ± IQR)
|
69 ± 30
|
56 ± 33
|
0.019
|
|
Gender (male)
|
24 (56) d
|
128 (55)
|
0.938
|
|
Immunocompromised
|
29 (67)
|
86 (37)
|
<0.001
|
|
Previous otitis
|
1 (2.1)
|
43 (19.5)
|
0.005
|
|
Fever
|
39 (91)
|
186 (84)
|
0.246
|
|
Headache
|
29 (67)
|
166 (77)
|
0.146
|
|
Vomiting
|
20 (46)
|
132 (57)
|
0.070
|
|
Neck stiffness
|
30 (70)
|
167 (72)
|
0.204
|
|
Classic Triad a
|
21 (49)
|
90 (39)
|
0.533
|
|
GCS b at admission (median ± IQR)
|
13 ± 4
|
12 ± 4
|
0.664
|
|
Seizures
|
4 (9)
|
17 (7)
|
0.688
|
|
Focal neurological deficit
|
14 (32)
|
27 (12)
|
0.022
|
|
Cerebellum dysfunction
|
5 (12)
|
5 (2)
|
<0.001
|
|
Hyponatremia
|
19 (44)
|
60 (26)
|
0.066
|
|
Duration of symptoms in hours (median ± IQR)
|
70 ± 53
|
48 ± 53
|
0.07
|
|
WBC count CSF c (median ± IQR)
|
550 ± 2480
|
2860 ± 9380
|
0.007
|
|
CSF neutrophils ( median±IQR)
|
70 ± 59
|
90 ± 13
|
<0.001
|
|
CSF/blood glucose (median ± IQR)
|
0.26 ± 0.24
|
0.09 ± 0.26
|
<0.001
|
|
Protein level g/L ( median ± IQR)
|
2.0 ± 1.96
|
3.68 ± 5.53
|
<0.001
|
|
Mortality
|
12 (29)
|
36 (16)
|
0.059
|
